Debbie Jakubowski

Validation of the 21-gene test as a predictor of clinical response to neoadjuvant hormonal therapy for ER+, HER2-negative breast cancer: the TransNEOS study

Hiroji Iwata, Norikazu Masuda, Yutaka Yamamoto et al. · Breast Cancer Research and Treatment · 2018 · 102 citations · Full text

Medicine, Oncology, Breast Oncology +16

Prognostic Impact of the 21-Gene Recurrence Score Assay Among Young Women With Node-Negative and Node-Positive ER-Positive/HER2-Negative Breast Cancer

Philip D. Poorvu, Shari Gelber, Shoshana M. Rosenberg et al. · Journal of Clinical Oncology · 2019 · 79 citations · Full text

Medicine, Cancer Biology, Oncology +16

Ten-year clinical outcomes in N0 ER+ breast cancer patients with Recurrence Score-guided therapy

Salomon M. Stemmer, Mariana Steiner, Shulamith Rizel et al. · npj Breast Cancer · 2019 · 30 citations · Full text

Medicine, Oncology, Breast Oncology +16

Molecular characterization of breast cancer needle core biopsy specimens by the 21‐gene Breast Recurrence Score test

Debbie Jakubowski, Helen D. Bailey, John Abran et al. · Journal of Surgical Oncology · 2020 · 24 citations · Full text

Medicine, Oncology, Pathology +16

Response to neoadjuvant chemotherapy and the 21-gene Breast Recurrence Score test in young women with estrogen receptor-positive early breast cancer

Tal Sella, Shari Gelber, Philip D. Poorvu et al. · Breast Cancer Research and Treatment · 2020 · 24 citations

Medicine, Oncology, Breast Oncology +15